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Abstract
Background: Compound K [20-O-β-(D-glucopyranosyl)-20(S)-protopanaxadiol], a metabolite of
the protopanaxadiol-type saponins of Panax ginseng C.A. Meyer, has been reported to possess anti-
tumor properties to inhibit angiogenesis and to induce tumor apoptosis. In the present study, we
investigated the effect of Compound K on apoptosis and explored the underlying mechanisms
involved in HL-60 human leukemia cells.
Methods: We examined the effect of Compound K on the viabilities of various cancer cell lines
using MTT assays. DAPI assay, Annexin V and PI double staining, Western blot assay and
immunoprecipitation were used to determine the effect of Compound K on the induction of
apoptosis.
Results: Compound K was found to inhibit the viability of HL-60 cells in a dose- and time-
dependent manner with an IC50 of 14 μM. Moreover, this cell death had typical features of
apoptosis, that is, DNA fragmentation, DNA ladder formation, and the externalization of Annexin
V targeted phosphatidylserine residues in HL-60 cells. In addition, compound-K induced a series of
intracellular events associated with both the mitochondrial- and death receptor-dependent
apoptotic pathways, namely, (1) the activation of caspases-3, -8, and -9; (2) the loss of mitochondrial
membrane potential; (3) the release of cytochrome c and Smac/DIABLO to the cytosol; (4) the
translocation of Bid and Bax to mitochondria; and (5) the downregulations of Bcl-2 and Bcl-xL.
Furthermore, a caspase-8 inhibitor completely abolished caspase-3 activation, Bid cleavage, and
subsequent DNA fragmentation by Compound K. Interestingly, the activation of caspase-3 and -8
and DNA fragmentation were significantly prevented in the presence of cycloheximide, suggesting
that Compound K-induced apoptosis is dependent on de novo protein synthesis.
Conclusions: The results indicate that caspase-8 plays a key role in Compound K-stimulated
apoptosis via the activation of caspase-3 directly or indirectly through Bid cleavage, cytochrome c
release, and caspase-9 activation.
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Background
Ginseng, the root and rhizomes of different Panax species
(Araliaceae), is one of the most commonly used as tradi-
tional medicines in East Asia. Furthermore, the saponins
of ginseng (ginsenosides) are its major active components
and have been shown to possess anti-inflammatory, anti-
tumor, and neuroprotective activities [1]. The pharmaco-
logical actions of these ginsenosides have been attributed
to their biotransformations by intestinal bacteria [2]. Pro-
topanaxadiol ginsenoside is metabolized primarily to 20-
O-β-(D-glucopyranosyl)-20(S)-protopanaxadiol (Com-
pound K, Figure 1A) by intestinal bacteria via the stepwise
cleavage of sugar moieties [3]. Furthermore, Compound K
has been shown to inhibit glucose uptake and to reverse
multi-drug resistance in tumor cells, but to be non-toxic to
normal cells [4]. Compound K has also been reported to
reverse benzo [a]pyrene-induced mutagenicity nd clas-
togenic activity [5], to inhibit tumor metastasis by sup-
pressing invasion [6], and to stimulate apoptosis in
several tumor cell lines [7,8].
Apoptosis is a selective process of physiological cell dele-
tion that plays an important role in the balance between
cellular replication and death. Furthermore, it has been
suggested that some cancer chemotherapeutics and chem-
opreventives exert their effects by triggering either apop-
totic cell death or cell cycle transition, and accordingly,
the induction of tumor cell apoptosis is used to predict
tumor treatment response [9,10]. Apoptotic signaling can
proceed via two pathways, i.e., via death receptors
expressed on the plasma membranes of cells or alterna-
tively via mitochondria, which contain several proteins
that regulate apoptosis. The death receptor pathway is ini-
tiated by the ligation of membrane bound tumor necrosis
factor (TNF) or Fas receptors, which result in a caspase-8-
dependent cascade and subsequent cell death [11]. Dur-
ing this cascade, caspase-8 cleaves Bid and induces cyto-
chrome c release and/or directly activates caspase-3 [12].
On the other hand, the mitochondrial pathway involves
cytochrome c release, which leads to caspase-9 activation
and a proteolytic caspase cascade [13]. Thus, caspase cas-
cades appear to be a central component in the apoptotic
process. However, accumulating evidence indicates that
apoptosis is also induced by caspase-independent path-
ways [14], which has been suggested to involve mitochon-
drial release of apoptosis-inducing factor (AIF) and/or
endonuclease G [15,16].
Human leukemia results from multiple mutations that
lead to abnormalities in the expressions and functions of
genes that maintain the delicate balance between prolifer-
ation, differentiation, and apoptosis. Continued research
on the molecular aspects of leukemia cells has resulted in
the developments of several potentially useful therapeutic
agents. In this context, we investigated that Compound K
induced apoptosis and the mechanism involved the acti-
vation of caspase-8 system.
Methods
Cells and reagents
HL-60 human promyelocytic leukemia, U-937 human
histocytic lymphoma, HeLa human negroid cervix epith-
eloid carcinoma, A549 human lung adenocarcinoma,
HepG2 human hepatoblastoma, P388 mouse lymphob-
last, and A431 human epidermoid carcinoma cells were
obtained from the Korean cell line bank (KCLB, Seoul,
Korea) and were cultured according to the KCLB recom-
mendations.
Compound K used in this study was isolated from Panax
ginseng and structural identities were determined spectro-
scopically (1H and 13NMR, IR, MS) as described previ-
ously [17]. The identity of isolated compound was
confirmed by LC-MS and was found to be >98% pure.
RPMI 1640 medium, fetal bovine serum (FBS), penicillin,
and streptomycin were obtained from Life Technologies
Inc. (Grand Island, NY). 3-(4,5-Dimethylthiazol-2-yl)-
2,5-diphenyl-tertazolium bromide (MTT), dimethyl sul-
foxide (DMSO), RNase A, leupeptin, aprotinin, phenyl-
methylsulfonylfluoride (PMSF), 4',6-diamidino-2-
phenylindole-dihydrochloride (DAPI), Triton X-100,
Nonidet P-40, protein A/G-Sepharose beads, and propid-
ium iodide (PI) were purchased from Sigma Chemical Co.
(St. Louis, MO). The following antibodies for caspase-3,
poly(ADP-ribose) polymerase (PARP), Bid, tBid, Bax, Bcl-
2, Bcl-xL, anti-Smac/DIABLO, Fas, FasL, α-tubulin and β-
actin were purchased from Santa Cruz Biotechnology
(Santa Cruz, CA). The antibodies for Fas-associated death
domain protein (FADD), X-linked inhibitor of apoptosis
protein (XIAP), caspase-8, caspsae-9, and cytochrome c
were purchased from BD Biosciences, Pharmingen (San
Diego, CA). The antibody for COX IV was purchased from
Cell Signaling Technology (Beverly, MA), and Bax 6A7
antibody was obtained from Trevigen, Inc. (Gaithersburg,
MD). z-VAD-fmk and z-DEVD-fmk, z-IETD-fmk, and z-
LEHD-fmk were purchased from Calbiochem (Bad Soden,
Germany).
MTT assay
The cytotoxicity was assessed using a MTT assay [18].
Briefly, the cells (5 × 104) were seeded in each well con-
taining 100 μL of the RPMI medium supplemented with
3% FBS in a 96-well plate. After 24 h, various concentra-
tions of Compound K were added. After 48 h, 50 μL of
MTT (5 mg/mL stock solution) was added and the plates
were incubated for an additional 4 h. The medium was
discarded and the formazan blue, which was formed in
the cells, was dissolved with 100 μLDMSO. The optical
density was measured at 540 nm.BMC Cancer 2009, 9:449 http://www.biomedcentral.com/1471-2407/9/449
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Compound K induced apoptosis in HL-60 cells Figure 1
Compound K induced apoptosis in HL-60 cells. (A) The chemical structure of Compound K. (B) Cells were treated with 
various concentrations (10, 15, 20 μM) of Compound K for the indicated times. Extents (%) of DNA fragmentation were 
determined by fluorometric method using DAPI, as described in Methods. Data are presented as means ± SD of three inde-
pendent experiments. *P < 0.05, **P < 0.01 and ***P < 0.001 vs. the control group; the significances of differences between 
treatments were determined using the Student's t-test. (C) Cells were treated with or without 20 μM Compound K for the 
indicated times. Fragmentation of genomic DNA was extracted and resolved on 2% agarose gels. Apoptotic DNA fragmenta-
tion was visualized by ethidium bromide staining. (D) Cells treated with or without 20 μM of Compound K for the indicated 
times were co-stained with PI and FITC-conjugated Annexin V, which specifically detected the translocation of phosphatidyl-
serine (PS). Cells were then examined by flow cytometry (LR; low right, UR; upper right).BMC Cancer 2009, 9:449 http://www.biomedcentral.com/1471-2407/9/449
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Detection and quantification of DNA fragmentation
DNA fragmentation was quantified using DAPI staining
and analysis of DNA fragmentation by agarose gel electro-
phoresis was performed as described previously [19]. In
brief, cells were lysed in a solution of 5 mM Tris-HCl (pH
7.4) and 1 mM EDTA containing 0.5% (w/v) Triton X-100
for 20 min on ice. After centrifugation at 25,000 g for 20
min, the lysate and supernatant were sonicated for 15 sec
and the level of DNA in each fraction was measured by a
fluorometric method using DAPI. The amount of the frag-
mented DNA was calculated as the ratio of the amount of
DNA in the supernatant to that in the lysate. Genomic
DNA was prepared and was performed in a 1.5% (w/v)
agarose gel in 40 mM Tris-acetate buffer (pH 7.4) at 50 V
for 1 h. The fragmented DNA was visualized by staining
with ethidium bromide after electrophoresis.
PI and Annexin V double staining
For PI and Annexin V double staining, cells were sus-
pended with 100 μl of binding buffer (10 mM HEPES/
NaOH, 140 mM NaCl, 2.5 mM CaCl2, pH 7.4) and
stained with 5 μL of FITC-conjugated Annexin V and 10
μL of PI (50 μg/mL) for 15 min at room temperature in
dark place and then added 400 μl binding buffer, and ana-
lyzed by the fluorescence-activated cell sorting (FACS)
cater-plus flow cytometry (Becton Dickinson Co, Heidel-
berg, Germany)
Analysis of mitochondrial membrane potential (MMP, 
ΔΨm)
Changes in mitochondrial transmembrane potential were
monitored by flow cytometric analysis. Cells were incu-
bated with 50 nM 3,3'-dihexyloxacarbocyanine iodide
(DiOC6) for 30 min, washed twice with PBS, and analyzed
by flow cytometric analysis (Becton Dickinson Co, Hei-
delberg, Germany) with excitation and emission settings
of 484 and 500 nm, respectively. To ensure that DiOC6
uptake was specific for ΔΨm, we also treated cells with 50
μM carbonyl cyanide m-chlorophenylhydrazone (CCCP)
or 5 μM cyclosporine A (CsA). CCCP was used as a refer-
ence depolarizing agent and CsA was used as an inhibitor
of mitochondrial permeability transition.
Protein extraction and Western blot analysis
Cells were collected by centrifugation at 200 g for 10 min
at 4°C. The cells were then washed twice with ice-cold
PBS, and centrifuged at 200 g for 5 min. The cell pellet
obtained was then resuspended in 1× protein lysis buffer
(Intron, Seoul, Korea). Equal amounts of cell lysates were
separated by SDS- polyacrylamide gel and transferred to
nitrocellulose membranes for Western blot analysis using
the indicated primary antibodies. HRP-conjugated sec-
ondary antibodies were detected using an ECL (Amer-
sham, Buckingham-shire, England) detection system.
Preparation of mitochondrial proteins
Cells were collected by centrifugation at 200 g for 10 min
at 4°C. The cells were then washed twice with ice-cold
PBS, and centrifuged at 200 g for 5 min. The cell pellet
obtained was then resuspended in ice-cold cell extraction
buffer (20 mM HEPES-KOH, pH 7.5, 10 mM KCl, 1.5 mM
MgCl2, 1 mM EDTA, 1 mM EGTA, 1 mM dithiothreitol,
100 μM PMSF, and protease inhibitor cocktail) for 30 min
on ice. The cells were then homogenized with a glass
dounce and a B-type pestle (80 strokes), homogenates
were spun at 15,000 g for 15 min at 4°C, and the super-
natant (cytosolic fraction) was removed whilst taking care
to avoid the pellet. The resulting pellet (mitochondrial
fraction) was resuspended in extraction buffer. Cell lysates
were fractionated in SDS- polyacrylamide gels and trans-
ferred to nitrocellulose membranes fot immunoblot anal-
ysis using the indicated primary antibodies. Immuno-
positive bands were visualized by ECL kit (Amersham,
Buckingham-shire, England).
Immunoprecipitation
After harvesting and washing, pellets were lysed in EBC
buffer (30 mM Tris-HCl, pH 7.5, 150 mM NaCl, 10% glyc-
erol, 1 mM EDTA, 2.5 mM EGTA, 5 mM NaF, 0.1 mM
Na3VO4, 1% Triton X-100 and protease inhibitor) for 15
min on ice. After centrifugation (10,000 g, 5 min), protein
concentrations were determined. Equal amount of pro-
tein (100 μg) was incubated with anti-Smac/DIABLO,
anti-tBid, anti-Bax, and anti-Fas antibodies for 12 h at
4°C, followed by incubation with 40 μL protein A-Sepha-
rose beads for 4 h. The protein complex was washed 4
times with EBC buffer and released from the beads by
boiling in 6× sample buffer (350 mM Tris, pH 6.8, 10%
SDS, 30% β-mercaptoethanol, 6% glycerol, 0.12%
bromophenolblue) for 5 min. The reaction mixture was
then resolved by a 10 - 12% SDS- polyacrylamide gels,
transferred to nitrocellulose membrane and probed with
anti-XIAP, anti-Bax 6A7 (Trevigen Inc., Gaithersburg,
MD), anti-Bcl-xL, anti-Bcl-2, anti-tBid, anti-Bax, anti-cas-
pase-8, anti-Fas, anti-FasL, and anti-FADD antibodies.
Immuno-positive bands were visualized by ECL kit
(Amersham, Buckingham-shire, England).
Statistical analysis
Data presented are the means ± S.D. of results from three
independent experiments with similar patterns. *P < 0.05,
** P < 0.01, *** P < 0.001 vs control group, †P < 0.05, ††
P < 0.01, ††† P < 0.001 vs Compound K-treated group; sig-
nificance of difference between treated groups by Stu-
dent's t-test.BMC Cancer 2009, 9:449 http://www.biomedcentral.com/1471-2407/9/449
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Results
Compound K inhibited HL-60 cell growth and induced 
apoptosis
We examined the effect of Compound K on the viabilities
of various cancer cell lines using MTT assays, and assessed
its effects using IC50 values (Table 1). IC50 values were
found to fall in the range 14.1 - 59.4 μM, and Compound
K was found to have marked cytotoxic effects on human
leukemia cell lines, including HL-60 and U937. Further
experiments were performed using HL-60 cells to evaluate
the effect of Compound K on apoptosis and to identify the
mechanism involved. To determine whether the cell
growth inhibitory effect of Compound K is associated
with the induction of apoptosis, DNA fragmentation was
evaluated using DAPI assay and by agarose gel electro-
phoresis. DAPI assay revealed that Compound K caused
DNA fragmentation, in a time- and dose-dependent man-
ner in HL-60 cells (Figure 1B). Furthermore, a typical lad-
der pattern of internucleosomal DNA fragmentation was
observed after treating HL-60 cells with Compound K (20
μM) for 4 h (Figure 1C). To further characterize Com-
pound K-induced apoptosis, we assessed the translocation
of phosphatidylserine (PS) using Annexin V and PI dou-
ble staining. As shown in Figure 1D, cell numbers in
lower-right quadrants, which correspond to early apop-
totic cells (Annexin V-positive), were increased up to 99%
after treating cells with Compound K (20 μM, for 1 h),
and about 92% of cells were in the late apoptotic stage
after 4 h.
Caspase involvement in Compound K-induced apoptosis
To identify the mechanism involved in Compound K-
induced apoptosis, we investigated the activation of cas-
pase-8, -9, -3, and the cleavage of PARP. As shown in Fig-
ure 2A, Compound K significantly increased the
activation of caspase-8, -9, -3 and the cleavage of PARP
(an endogenous substrate of caspase-3) in a time-depend-
ent manner. Following treatment with Compound K, the
cleaved form s of caspase-8 and -3 were observed at 0.5 h
and 1 h, respectively, whereas caspase-9 and PARP were
cleaved after 3 h of treatment in HL-60 cells. Additionally
Figure 2B showed that z-VAD-fmk (a broad caspase inhib-
itor), z-DEVD-fmk (a specific caspase-3 inhibitor), and z-
IETD-fmk (a specific caspase-8 inhibitor) all markedly
attenuated Compound K-stimulated DNA fragmentation,
thus indicating that Compound K-induced apoptosis is
largely dependent on the activation of caspases-8 and -3.
In contrast, z-LEHD-fmk (a specific caspase-9 inhibitor)
only partially inhibited DNA fragmentation.
Compound K induced apoptosis involving the loss of ΔΨm 
and the release of cytochrome c and Smac/DIABLO
Because Compound K induced caspase-9 cleavage in HL-
60 cells, the initial caspase in the mitochondrial apoptotic
pathway, we investigated whether Compound K was capa-
ble of inducing ΔΨm depolarization using DiOC6, a mito-
chondria-specific voltage-dependent dye. Treatment of
cells with Compound K (20 μM) caused the dissipation of
ΔΨm, as did CCCP (the positive control) (Figure 3A). In
order to determine whether this loss of ΔΨm was associ-
ated with Compound K-induced apoptosis, we utilized
CsA (5 μM; an inhibitor of mitochondrial permeability
transition). Pretreatment with CsA significantly inhibited
the Compound K-induced loss of ΔΨm and caspase-3 acti-
vation, but had no effect on caspase-8 activation (Figure
3B). Additionally, DAPI staining and agarose gel electro-
phoresis assays showed that CsA partially inhibited Com-
pound K-induced DNA fragmentation (Figure 3C and
3D), indicating that ΔΨm is partially involved in Com-
pound K-induced apoptosis. Furthermore the levels of
cytosolic cytochrome c and Smac/DIABLO were elevated
by Compound K in HL-60 cells, whereas X-linked IAP
(XIAP) levels decreased, which suggests the involvement
of the mitochondrial pathway (Figure 3E). To determine
whether Smac/DIABLO release by Compound K is able to
dissociate XIAP from caspases, we immunoprecipitated
Smac/DIABLO, and detected bound XIAP by Western
blotting. We found that Compound K significantly
increased the interaction between Smac/DIABLO and
XIAP (Figure 3F). The above results suggest that Com-
pound K stimulates the release of Smac/DIABLO from
mitochondria and the association between Smac/DIABLO
and XIAP, and that this inhibits the XIAP - caspase inter-
action and consequently stimulates apoptosis.
Compound K induced the translocations of tBid and Bax 
and downregulated Bcl-2 and Bcl-xL
To investigate the mechanism underlying Compound K-
induced ΔΨm changes in HL-60 cells, we examined the
translocations of cytosolic Bid and Bax into mitochondria
after treating cells with Compound K. As shown in Figure
4A, treatment with Compound K reduced the cytosolic
levels of pro-apoptotic Bid and Bax, but increased their
mitochondrial levels. In addition, the mitochondrial
expressions of Bcl-2 and Bcl-xL (mitochondrial anti-apop-
Table 1: Cell viabilities of Compound K in various cancer cell 
lines in vitro








aIC50 is defined as the concentration that results in a 50% decrease in 
the number of cells compared to that of the control cultures in the 
absence of Compound K. The values represent the means of results 
from three independent experiments with similar patterns.BMC Cancer 2009, 9:449 http://www.biomedcentral.com/1471-2407/9/449
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Compound K induced the apoptosis of HL-60 cells via caspase activation Figure 2
Compound K induced the apoptosis of HL-60 cells via caspase activation. (A) Cells were treated with 20 μM of 
Compound K for the indicated times. Caspase-8, caspase-9, caspase-3, and PARP were analyzed by Western blotting. β-actin 
was used as an internal control. Experiments were repeated three times and similar results were obtained. (B) Effects of the 
caspase inhibitors (z-VAD-fmk, z-DEVD-fmk, z-IETD-fmk and z-LEHD-fmk) on apoptosis were determined by testing for Com-
pound K-induced DNA fragmentation. HL-60 cells were pretreated with/without 50 μM z-VAD-fmk, 100 μM z-DEVD-fmk, 
100 μM z-IETD-fmk or 100 μM z-LEHD-fmk for 1 h, and then treated with Compound K (20 μM for 2 h). DNA fragmentation 
was measured by DAPI staining. White square: None, Black square: Compound K. The data presented are the means ± SD of 
results obtained from three independent experiments. ***P < 0.001 vs. control group, ††P < 0.01, †††P < 0.001 vs. the Com-
pound K-treated group; significances were determined using the Student's t-test.BMC Cancer 2009, 9:449 http://www.biomedcentral.com/1471-2407/9/449
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Figure 3 (see legend on next page)BMC Cancer 2009, 9:449 http://www.biomedcentral.com/1471-2407/9/449
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Compound K caused a loss in mitochondrial membrane potential and induced the translocations of cytochrome c and Smac/ DIABLO from mitochondria to the cytoplasm in HL-60 cells Figure 3 (see previous page)
Compound K caused a loss in mitochondrial membrane potential and induced the translocations of cyto-
chrome c and Smac/DIABLO from mitochondria to the cytoplasm in HL-60 cells. (A) Cells were pretreated with 5 
μM cyclosporin A (CsA) for 30 min and then treated with 20 μM of Compound K for 2 h, stained with DiOC6, and analyzed by 
flow cytometry. CCCP (100 μM) was used as a positive control. (B) Cells were pretreated as described in the legend of Figure 
3 (A). Cleavages of procaspase-8 and -3 were analyzed by Western blotting. DNA fragmentation was measured using (C) DAPI 
assays and (D) fragmented genomic DNA was extracted and resolved on 2% agarose gel. Data presented are the means ± SD 
of three independent experiments. ***P < 0.001 vs. untreated controls, †P < 0.05 vs. Compound K-treated cells; significances 
were determined using the Student's t-test. (E) Cells were harvested after being incubated with Compound K at 20 μM for the 
indicated times. Mitochondrial (M) and cytosolic (C) fractions were prepared as described in Methods. Cytochrome c, Smac/
DIABLO, and XIAP were analyzed by Western blotting. α-tubulin, cytochrome c oxidase (COX) IV, and β-actin were used as 
internal controls. (F) Compound K induced an interaction between XIAP and Smac/DIABLO. Cells were treated with 20 μM of 
Compound K for the indicated times. Smac/DIABLO was immunoprecipitated from total protein lysates and proteins were 
subjected to Western blotting for anti-XIAP antibody (IP: immunoprecipitation, IB; immunoblotting).
Effect of Compound K on the expressions of Bcl-2 family proteins for Compound K-induced apoptosis in HL-60 cells Figure 4
Effect of Compound K on the expressions of Bcl-2 family proteins for Compound K-induced apoptosis in HL-60 
cells. (A) Cells were harvested after being incubated with Compound K (20 μM) for the indicated times. Mitochondrial (M) 
and cytosolic (C) fractions were prepared as described in Methods. Bid, tBid, Bax, Bcl-2, and Bcl-xL were analyzed by Western 
blotting. α-tubulin, COX IV and β-actin were used as internal controls. (B) HL-60 cells were treated with 20 μM of Compound 
K for 4 h and cell lysates were prepared. Bax was immunoprecipitated from total protein lysates and proteins were subjected 
to Western blotting for anti-Bax 6A7 using specific antibody. (C) Compound K-induced interactions between Bcl-2 family 
members. tBid and Bax were immunoprecipitated using specific antibodies from total protein lysates and Western blotting was 
conducted for Bcl-2 and Bcl-xL (IP; immunoprecipitation, IB; immunoblotting).BMC Cancer 2009, 9:449 http://www.biomedcentral.com/1471-2407/9/449
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totic proteins) were reduced by Compound K. It has been
shown that apoptotic stimuli trigger a conformational
change in Bax and induce its translocation to mitochon-
dria [20]. As shown in Figure 4B, immunoprecipitation
assays were performed using an anti-Bax 6A7 antibody
recognizing only conformationally changed Bax, and
Compound K induced a time-dependent increase in con-
formationally changed Bax. Furthermore, treatment with
Compound K for 4 h, significantly enhanced bindings of
tBid to Bcl-2 or Bcl-xL, and increased association between
Bax and Bcl-2 or Bcl-xL (Figure 4C). These results suggest
the Compound K-induced translocations of tBid and Bax
stimulates their direct binding to Bcl-2 or Bcl-xL in mito-
chondria, and that this perturbs the balance between anti-
and pro-apoptotic Bcl-2 family proteins in mitochondria.
Compound K induced apoptosis via the caspase-8- 
dependent pathway
Because Compound K induced caspase-8 activation and
Bid cleavage (Figure 2A and 4A), we further examined the
mechanism of caspase-8 activation during Compound K-
induced apoptosis using z-IETD-fmk. As shown in Figure
5A, treatment with z-IETD-fmk inhibited caspase-3 activa-
tion, Bid translocation, and Bcl-2 downregulation by
Compound K. Furthermore, Compound K-induced inter-
nucleosomal DNA fragmentation was markedly abol-
ished in the presence of z-IETD-fmk (Figure 5B). To
determine whether DISC (death-inducing signaling com-
plex) formation is involved in the Compound K-induced
activation of caspase-8 and apoptosis, Fas was immuno-
precipitated and bindings of FasL, FADD, and procaspase-
8 to Fas were evaluated by Western blotting (Figure 5C).
The association of Fas with FasL and FADD was observed
from 0.5 h after Compound K treatment, while the bind-
ing of procaspase-8 to Fas was observed at 1 h. These find-
ings suggest that Compound K stimulates DISC formation
and the subsequent activation of procaspase-8.
Cycloheximide prevented Compound K-induced caspase-8 
and -3 activation and DNA fragmentation
To test the possibility that new protein synthesis is
required for Compound K-induced apoptosis, HL-60 cells
Effect of Compound K on the requirement for caspase-8 for Compound K-induced apoptosis in HL-60 cells Figure 5
Effect of Compound K on the requirement for caspase-8 for Compound K-induced apoptosis in HL-60 cells. (A) 
HL-60 cells were pretreated with/without 100 μM z-IETD-fmk (a specific caspase-8 inhibitor) for 1 h and then treated with 20 
μM of Compound K for 4 h. Mitochondrial (M) and cytosolic (C) fractions were prepared as described in Methods. Caspase-3, 
Bid, and tBid were analyzed by Western blotting. Anti-α-tubulin, anti-COX IV and anti-β-actin were used as internal controls. 
(B) Samples were treated as described in the legend of Figure 5(A). Genomic DNA fragments were extracted and resolved on 
2% agarose gel. Apoptotic DNA fragmentation was visualized by ethidium bromide staining. (C) Fas was immunoprecipitated 
from total protein lysates and proteins were subjected to Western blotting for anti-FasL, anti-FADD, or anti-caspase-8 anti-
bodies (IP: immunoprecipitation, IB; immunoblotting).BMC Cancer 2009, 9:449 http://www.biomedcentral.com/1471-2407/9/449
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were preincubated with cycloheximide (1 μg/mL for 1 h);
a protein synthesis inhibitor and then treated with Com-
pound K for 4 h. Cycloheximide completely inhibited the
activation of caspase-8 and -3 and DNA fragmentation
(Figures 6A and 6B) by Compound K, indicating that de
novo  protein synthesis is required for Compound K-
induced apoptosis.
Discussion
Compound K is a novel ginseng saponin metabolite that
is formed by the action of intestinal bacteria on ginseng
extract in man and rats [3]. The intestinal bacteria Prevo-
tella oris, which is responsible for the hydrolysis of ginse-
noside Rb1 to Compound K, has been found in 79% of
human fecal specimens [21]. Since Compound K was
detected in blood after oral administration of ginsenoside
Rb1 to mice, it has been speculated that it is probably the
major form of protopanaxadiol saponin absorbed by the
intestine. Furthermore, evidence that Compound K is the
active metabolite responsible for the anti-carcinogenic
effects of ginseng saponins has prompted several groups
to investigate its effects in detail [22-26].
Compound K has been reported to have potent anti-tum-
origenic activity, and in particular, to inhibit 12-O-tetra-
decanoylphorbol-13-acetate (TPA)-induced tumor
promotion in mouse skin, and COX-2 expression in
mouse skin and in cultured human mammary epithelial
cells [22]. In addition, Compound K has been reported to
inhibit glucose uptake by tumor cells and to reverse multi-
drug resistance in bacterial and tumor cells [23]. Com-
pound K was also found to have antiangiogenic activities
in a spontaneous metastasis model [24,27], and to inhibit
the expression of matrix metalloproteinase (MMP)-9,
which regulates the growth and invasiveness of brain
tumors [24]. It has also been reported to induce apoptosis
in activated rat hepatic stellate [25] and hepatoma [7,26]
cancer cells. However, the effects of Compound K on
leukemia have not been studied in detail, although Lee et
al  found that Compound K induced apoptosis via the
cytochrome c-mediated activation of caspase-3 in HL-60
cells [28]. Our present results confirm those of Lee et al.,
in as much as Compound K showed cytotoxic and apop-
tosis-inducing activities in HL-60 cells.
Apoptosis is a fundamental cellular activity and provides
protection against cancer development by eliminating
genetically altered cells and hyper-proliferative cells. Thus,
defects in apoptosis signaling pathways contribute to car-
cinogenesis and chemoresistance [29]. As mentioned
above, there are two major apoptotic pathways; the extrin-
sic death receptor-mediated pathway and the intrinsic
mitochondria-mediated pathway, and truncated Bid pro-
tein provides cross-talk between the two [30]. Both of
these pathways are regulated by caspases, which are
responsible, either directly or indirectly, for the cleavages
of cellular proteins, a characteristic of apoptosis [31]. In
the present study, Compound K increased the levels of
cleaved caspase-8, -9, and -3 and PARP in a time-depend-
ent manner and pretreatment with various caspase inhib-
itors markedly prevented Compound K-induced DNA
fragmentation (Figure 2). These findings indicate that cas-
pase-3 and -8 play fundamental roles in Compound K-
induced apoptosis in HL-60 cells. It is noteworthy that the
specific inhibition of caspase-9 by z-LEHD-fmk had only
a mild inhibitory effect on Compound K-stimulated
apoptosis. In this regard, it appears that activation of the
intrinsic mitochondria-mediated pathway alone is not
sufficient to explain the apoptotic effects of Compound K
in HL-60 leukemia cells. In addition, caspase-9 was acti-
vated about 2 h after treatment with Compound-K while
activation of caspase-3 was observed at 0.5 h. Recent stud-
ies have suggested that caspase-3 has feedback action on
caspase-9 [32]. For example, caspase-3-mediated activa-
tion of caspase-9 was involved in cisplatin-induced apop-
tosis [33]. This data suggested a possibility that tBid/
caspase 9 activation is a consequence of active caspase 3 in
the Compound-K-induced apoptosis.
Activation of the intrinsic mitochondrial pathway leads to
the release of Smac/DIABLO, which removes the IAP
blockage of caspase activation [34]. The IAP family, which
includes XIAP and survivin, functions by binding to and
inhibiting several caspases [35]. In the present study, we
observed Smac/DIABLO increased in cytoplasm and cor-
respondingly decreased in mitochondria after treating
cells with Compound K (data not shown), which suggests
that the translocation of Smac/DIABLO from mitochon-
dria to cytoplasm contributes to Compound K-induced
apoptosis in HL-60 leukemia cells. Furthermore, Com-
pound K-induced releases of cytochrome c and Smac/DIA-
BLO from mitochondria were seemingly associated with
mitochondrial depolarization (Figure 3A). Bid, a BH3-
only proapoptotic member of the Bcl-2 family, undergoes
proteolysis by caspase-8 activated by cell surface death
receptors, such as, Fas or TNF [36,37], and the tBid so pro-
duced, translocates to mitochondria and binds to anti-
apoptotic proteins, such as, Bcl-2 and Bcl-xL, which leads
to a conformational change in Bax, mitochondrial depo-
larization, and cytochrome c release from mitochondria
[38]. Moreover, conformationally altered Bax stimulates
the release of Smac/DIABLO from mitochondria [34], and
the cytochrome c-releasing activity of Bid by cell surface
death receptors such as Fas and TNF is antagonized by Bcl-
2 [37].
In the present study, Compound K-induced releases of
cytochrome  c  and Smac/DIABLO from mitochondria
were seemingly associated with mitochondrial depolari-
zation (Figure 3) and Compound K increased the translo-BMC Cancer 2009, 9:449 http://www.biomedcentral.com/1471-2407/9/449
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cations of Bid and Bax to mitochondria and their bindings
to Bcl-2 and Bcl-xL, which is presumed to induce a confor-
mational change in Bax and to reduce the mitochondrial
levels of Bcl-2 and Bcl-xL in HL-60 cells (Figure 4). These
findings suggest that the tBid triggered-imbalance
between pro- and anti-apoptotic Bcl-2 family members is
associated with the mitochondrial membrane depolariza-
tion that leads to the releases of cytochrome c and Smac/
DIABLO in Compound K-treated cells.
The bindings of FasL, TRAIL, and TNF to their cell surface
receptors are known to lead to caspase-8 activation, which
then amplifies the apoptotic signal either by directly acti-
vating downstream caspases or by cleaving Bid, a BH3-
only proapoptotic member of the Bcl-2 family [30]. In the
present study, caspase-8 inhibition prevented the cleav-
ages of Bid and caspase-3 and subsequent apoptosis (Fig-
ure 5A), which suggests that Bid is a substrate of caspase-
8, and that caspase-8 is required for Compound K-
induced apoptosis. Furthermore, we found that Com-
pound K stimulates DISC formation with the FasL, Fas,
FADD, and procaspase-8, which indicates that Com-
pound K-induced caspase-8 activation is probably due to
the stimulation of the death receptors. The mechanism by
which Compound K promotes DISC formation appears to
be dependent on de novo protein synthesis since the Com-
pound K-induced activation of caspases-8 and -3 and
DNA fragmentation were prevented by cycloheximide.
During our earlier studies, we found FasL is abundantly
expressed in HL-60 cells, and that Compound K increases
Fas protein expression in a time-dependent manner, but
does not affect FasL (data not shown). In this regard, we
speculate that Compound K stimulates apoptosis by
upregulating Fas in HL-60 cells. Indeed, in a previous
study, the triterpene saponin platycodin D was demon-
strated to induce DNA fragmentation and caspase-3/-8
activation within 3 h in immortalized keratinocyte HaCa
cells [39]. Recent studied have demonstrated that the gen-
eral translation rate is about 2-2.8 amino acid/sec suggest-
ting that it would take only 15 min to make a 50% change
in protein concentration [40,41]. Furthermore, Fas and
FasL protein upregulations were observed at 15 and 30
min, respectively, after platycodin D treatment, and NF-
κB activation (mediated by the degradation of IκB) was
found to be involved in these upregulations. Other studies
have also demonstrated the involvement of NF-κB in the
regulation of Fas and FasL expression in a variety of cell
lines [42,43]. However, whether Compound K-induced
apoptosis is mediated by NF-κB-regulated Fas expression
in HL-60 cells remains to be determined. Taken together,
we hypothesize Compound K-induced apoptosis in HL-
60 cells is associated with the upregulations of cleaved
caspases-8 and -3, tBid, and mitochondrial membrane
depolarization, and that crosstalk between the caspase-8/
Bid and mitochondrial pathways appears to contribute to
Compound K-induced apoptosis.
Conclusion
Our results demonstrate that Compound K inhibit the
viability of HL-60 cells and these effects were mediated
through the induction of apoptosis. Compound K
induced the activation of caspase-3, -8, and -9, and mod-
ulation of Bcl-2 families. In addition, a caspase-8 inhibi-
tor completely abolished caspase-3 activation, Bid
cleavage, and subsequent DNA fragmentation by Com-
pound K. Therefore caspase-8 plays a key role in Com-
pound K-stimulated apoptosis. Based on these finding, we
suggest that Compound K may be used as a potential ther-
apeutic and chemopreventive agent for leukemia via the
potent apoptotic activity.
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